Business Wire

GA-CYBLE

3.6.2024 16:25:28 CEST | Business Wire | Press release

Share
Cyble Welcomes Cybersecurity Expert Steve Ingram to Advisory Board

Cyble, the leading provider of AI-driven cybersecurity solutions, has appointed Steve Ingram to its advisory board. Ingram will play an important role in advancing Cyble’s vision and strengthening its market position.

Ingram's distinguished career spans more than three decades and includes appointments at multiple prestigious global consulting firms. He most recently served as the Financial Services Cyber Leader for the Americas at EY (Ernst & Young), where he was instrumental in developing and implementing advanced cybersecurity strategies for major financial institutions. He also was the Asia-Pacific Cyber Leader at PwC, where he served as a partner for 15 years. There he led significant cybersecurity initiatives and guided clients through the complexities of cyber risk management in one of the world’s most dynamic regions, where he was a member of the ASEANZ Markets Council.

“Cyble is well-positioned to strengthen organizations’ cyber posture, and I look forward to supporting the company as it expands,” Ingram said. “The best way to prevent large-scale cyberattacks is to detect and mitigate threats before they happen, and AI is fast becoming a crucial factor in that process. My visibility into cybersecurity challenges and investments in solutions will help Cyble and its customers stay one step ahead of attackers.”

Cyble recently launched AmIBreached 3.0, its most extensive dark web monitoring engine, and Cyble Vision X, the successor to its award-winning Cyble Vision 2.0 threat intelligence platform, to further enable businesses to anticipate and respond to the changing threat environment.

“Steve’s rich experience and deep understanding of the cybersecurity landscape will provide us with valuable insights as we accelerate Cyble’s product innovation and expansion,” said Beenu Arora, CEO of Cyble. “He will support our commitment to delivering advanced, AI-based cybersecurity solutions to organizations around the world.”

To learn how Cyble can improve your security posture, visit https://www.cyble.com.

About Cyble
Cyble, a trailblazer in Cyber Threat Intelligence, is committed to democratizing Dark Web Threat Intelligence through advanced AI and Machine Learning solutions. Recognized as one of the most sought-after workplaces, Cyble’s culture fosters innovation, collaboration, and professional growth.

With a proven track record in delivering cutting-edge research and proactive monitoring, Cyble stands at the forefront of the cybersecurity landscape. Headquartered in Atlanta, Georgia, with a global presence spanning Australia, Malaysia, Singapore, Dubai, Saudi Arabia, and India, Cyble is the trusted authority empowering organizations to proactively combat evolving cyber threats.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240603346902/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release

Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release

Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release

Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye